Stereotactic Ablative Radiotherapy (SABR) is an external beam treatment modality that delivers high precision large doses of radiation. In simple words, it is a way of giving Radiotherapy to precisely target cancer…
Tag: Treatment Options For Lung Cancer
Combination Of Radiation And Immunotherapy For Advanced Non-Small Cell Lung Cancer
According to the new study by researchers from the UCLA Health Jonsson Comprehensive Cancer Center, using high doses of radiation with an ablative radiotherapy technique is effective for treatment with locally advanced…
New Study Finds A Way To Stop Key Lung Cancer Spread Protein
Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…
Stereotactic Ablative Radiotherapy (SABR) For Lung Cancer
In lung cancer treatment, Stereotactic Ablative Radiotherapy (SABR) is rapidly been used as an important radiation tool. SABR is being evaluated for treatment of medically inoperable lung cancer, operable lung cancers, metastases…
Nanoparticle Vaccine Could Curb Lung Cancer Metastasis
The engineers at the University of California San Diego have come up with an experimental vaccine that could prevent the spread of metastatic cancers to the lung. The key ingredients of this…
Trial Shows Novel Vaccine’s Potential for Lung Cancer Treatment
A new vaccine has shown to improve survival rate among people suffering from lung cancer. A French biotechnology company said that Ose Immunotherapeutics’ Tedopi vaccine was effective in decreasing death risk among lung…
Tumor Treating Fields to Improve Survival Benefit in Lung Cancer
Tumor Treating Fields (TTFields) are electric fields that disrupt processes which are critical for the survival of cancer cells. This leads to immunogenic cell death and enhanced antitumor immune response. The use…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa Immunogene Therapy (quratusugene…
ctDNA Testing To Reduce Time For Lung Cancer Treatment
According to the American Society of Clinical Oncology, around 2.4lac adults in the United States will be diagnosed with lung cancer of which 81% are NSCLC. Early diagnosis and treatment is one…
Sublober Resection for Surgical Treatment of Non-Small Cell Lung Cancer
Lung cancer is among common forms of cancers and is responsible for most deaths from cancers all over the world. One standard care for lung cancer is labectomy for surgical treatment of…
Lung Cancer Outcomes May Be Improved By Chemo With TKI Drug
Gefitinib and chemotherapy may be considered a first-line treatment option for patients with EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) with brain metastases. Recent research has shown that patients with Epidermal Growth Factor…